BSECorp. ActionDividend13 Aug 2026
Honasa Consumer Ltd
The Company has fixed August 28, 2026 as the Record Date for determining the eligibility of members entitled to receive the final dividend of Rs. 3 per equity share for the financial year ....
Honasa Consumer Ltd has fixed August 28, 2026 as the record date for determining the eligibility of members entitled to receive the final dividend of Rs. 3 per equity share for the financial year 2025-26.
BSEResultResults13 Aug 2026
Honasa Consumer Ltd
Unaudited Financial Results for the quarter ended June 30, 2026
Honasa Consumer Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the company's board of directors approving the results based on the recommendation of the Audit Committee. The results include the unaudited standalone and consolidated financial results of the company for the quarter, along with a limited review report issued by the Statutory Auditors.
BSECompany Update▲ PositiveResults13 Aug 2026
Honasa Consumer Ltd
Press Release on the unaudited financial results for the quarter ended June 30, 2026
Honasa Consumer Ltd reported its unaudited financial results for Q1FY27, with revenue growing 31.8% YoY to INR 785 Cr and EBITDA more than doubling to INR 110 Cr. The company delivered its highest-ever quarterly revenue and profit, with a healthy 14.1% margin.
BSECompany Update▲ PositiveResults13 Aug 2026
Honasa Consumer Ltd
Investor Presentation on the unaudited financial results for the quarter ended June 30, 2026
Honasa Consumer Ltd has released an investor presentation on its unaudited financial results for the quarter ended June 30, 2026, highlighting its growth in the I-beauty segment, particularly in the fragrance and color cosmetics categories.
BSEBoard MeetingResults13 Aug 2026
Honasa Consumer Ltd
Outcome of Board Meeting held today i.e. August 13, 2026
Honasa Consumer Ltd's board of directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, based on the recommendation of the Audit Committee. The financial results along with limited review reports are enclosed.
BSECompany UpdateMgmt Change11 Aug 2026
Honasa Consumer Ltd
Schedule of Meeting with Analysts/Investors
Honasa Consumer Ltd has announced a schedule of meeting with analysts/investors on August 18, 2026, at Ambit-Daiwa India Access in Singapore.
BSECompany UpdateLitigation8 Aug 2026
Honasa Consumer Ltd
Cassation Court, Dubai, UAE Judgement in the matter of RSM General Trading LLC
Honasa Consumer Ltd has received a judgment from the Cassation Court, Dubai, UAE, in the matter of RSM General Trading LLC, awarding AED 1,707,407.06 to RSM for material and moral damages. The Company expects no financial impact due to the reliefs granted by the Arbitral Tribunal.
BSECompany Update▲ PositiveMgmt Change6 Aug 2026
Honasa Consumer Ltd
Update on Senior Management
Honasa Consumer Ltd has elevated Nilesh Kotalwar as Chief Marketing Officer, effective August 06, 2026, to lead the company's integrated marketing function across its portfolio of brands.
BSECompany UpdateResults31 Jul 2026
Honasa Consumer Ltd
Schedule of Q1 FY 2027 Earnings Conference Call - August 13, 2026
Honasa Consumer Ltd has scheduled a Q1 FY 2027 earnings conference call for August 13, 2026, to discuss unaudited financial results for the quarter ended June 30, 2026.
BSEBoard MeetingResults29 Jul 2026
Honasa Consumer Ltd
Honasa Consumer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve unaudited financial results ....
Honasa Consumer Ltd has scheduled a Board meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
BSECompany Update▲ PositiveM&A23 Jun 2026
Honasa Consumer Ltd
Press release
Honasa Consumer Ltd. announced the strategic acquisition of a 58% majority stake in Fluence Pharma, a science-backed nutraceuticals company known for its patented Cyclical Nutrition Therapy and dermatologist network. This acquisition marks Honasa's entry into the high-growth nutraceuticals category, specifically targeting "inside-out" beauty, under a newly formed subsidiary, Honasa Health. Fluence Pharma reported ~INR 40 Crore revenue and over 20% EBITDA margin in FY26, and Honasa aims to leverage Fluence's science with its own brand-building and digital distribution capabilities.
BSECompany Update▲ PositiveM&A23 Jun 2026
Honasa Consumer Ltd
Approval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary
Honasa Consumer Ltd announced the acquisition of a 58% equity stake in Fluence Pharma Private Limited, a company offering condition-specific OTC supplements under brands like "Hair Fact, Skin Fact, and Pro Fact." The acquisition, valued at approximately ₹135 Crores enterprise value for the initial stake, strategically marks Honasa's entry into the high-growth nutraceuticals market, with plans to acquire the remaining 42% over the next 5-7 years. Additionally, Honasa will incorporate a wholly-owned subsidiary, 'Honasa Health Private Limited,' to manage its new B2C nutraceuticals operations.